In a recent cross-sectional study, it was shown that people with a good observed upper limb (UL) motor function but low perceived UL activity show a reduced daily-life UL activity. The investigators will now investigate the feasibility of a phone-monitored home exercise and feedback program for the UL following stroke and the preliminary effects on the perceived UL activity and actual daily-life UL activity for participants with good observed UL motor function but low perceived UL activity in the chronic phase post-stroke.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
19
Combination of the Home-Graded Repetitive Arm Supplementary Program with in home accelerometer-based feedback
Private physiotherapy practices
Leuven, Belgium
Recruitment rate
% of individuals who were eligible and agreed to participate
Time frame: 45 days (post-intervention)
Retention rate
% of participants who completed the intervention
Time frame: 45 days (post-intervention)
Adherence to the intervention protocol
% of participants who achieved 12 hours of average weekly exercise
Time frame: 45 days (post-intervention)
Safety
\# of participants with increased pain while performing exercises as measured by visual analogue scale
Time frame: 45 days (post-intervention)
Activity ratio
Contribution to the activity of one upper limb (UL) versus the other: hours of activity of the affected divided by the unaffected UL
Time frame: Day 1 (enrolment)
Activity ratio
Contribution to the activity of one upper limb (UL) versus the other: hours of activity of the affected divided by the unaffected UL
Time frame: Day 17 (baseline)
Activity ratio
Contribution to the activity of one upper limb (UL) versus the other: hours of activity of the affected divided by the unaffected UL
Time frame: 45 days (post-intervention)
Hand subscale of the Stroke Impact Scale version 3.0 (SIS-Hand)
Perceived activity of the affected UL. Minimum 0 - maximum 100; higher scores mean better outcome.
Time frame: Day 1 (enrolment)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hand subscale of the Stroke Impact Scale version 3.0 (SIS-Hand)
Perceived activity of the affected UL. Minimum 0 - maximum 100; higher scores mean better outcome.
Time frame: Day 17 (baseline)
Hand subscale of the Stroke Impact Scale version 3.0 (SIS-Hand)
Perceived activity of the affected UL. Minimum 0 - maximum 100; higher scores mean better outcome.
Time frame: 45 days (post-intervention)
Fugl-Meyer motor assessment - upper extremity (FMA-UE)
Observed motor function of the affected UL (shoulder, arm, wrist, hand, and fingers)
Time frame: Day 1 (enrolment), day 17 (baseline), 45 days (post-intervention)
Action Research Arm Test (ARAT)
Grasp, grip, pinch and gross movement of the affected UL
Time frame: Day 17 (baseline), 45 days (post-intervention)
Motor Activity Log - 14 Item Version Amount Of Use (MAL-14 AOU)
Patient-reported amount of UL use in daily life
Time frame: Day 17 (baseline), 45 days (post-intervention)
Motor Activity Log - 14 Item Version Quality Of Movement (MAL-14 QOM)
Patient-reported quality of UL use in daily life
Time frame: Day 17 (baseline), 45 days (post-intervention)
Erasmus modified Nottingham Sensory Assessment (Em-NSA)
Sensory assessment of the UL
Time frame: Day 17 (baseline), 45 days (post-intervention)
simplified modified Rankin Scale questionnaire (smRSq)
Global disability. Minimum 0 - maximum 5; higher scores mean worse outcome.
Time frame: Day 17 (baseline), 45 days (post-intervention)
Hospital Anxiety and Depression Scale (HADS)
Symptoms of anxiety and depression. Minimum 0 - maximum 42; higher scores mean worse outcome.
Time frame: Day 17 (baseline), 45 days (post-intervention)
Confidence in Arm and Hand Movement Scale (CAHM)
Perceived self-efficacy in performing tasks with the affected UL. Minimum 0 - maximum 100; higher scores mean better outcome.
Time frame: Day 17 (baseline), 45 days (post-intervention)
Visual Analogue Scale (VAS)
Pain intensity in the affected UL from 0 (no pain) to 10 (extreme). Minimum 0, maximum 10, higher scores mean worse outcome.
Time frame: Day 17 (baseline), 45 days (post-intervention)
EuroQol Five Dimensions Five Levels Questionnaire (EQ-5D-5L)
Health-related quality of life. Minimum 0, maximum 100, higher scores mean better outcome.
Time frame: Day 17 (baseline), 45 days (post-intervention)
Hours of UL activity
Sum of all seconds recorded when the activity count was nonzero and converted to hours
Time frame: Day 1 (enrolment), day 17 (baseline), 45 days (post-intervention)
Bilateral magnitude
Intensity of the movement: sum of the vector magnitude from the two ULs
Time frame: Day 1 (enrolment), day 17 (baseline), 45 days (post-intervention)
Magnitude ratio
Contribution to the activity of one limb versus the other: natural log of the vector magnitude of the affected UL divided by the vector magnitude of the unaffected UL, whereby values greater than and less than -7 were replaced by 7 and -7, respectively, to categorize single limb movement.
Time frame: Day 1 (enrolment), day 17 (baseline), 45 days (post-intervention)
Density plot
Graphical representation of accelerometry data from both ULs
Time frame: Day 1 (enrolment), day 17 (baseline), 45 days (post-intervention)